SynOx Therapeutics Ltd was founded in November 2020 and is solely focused on developing emactuzumab for the treatment of diffuse tenosynovial giant cell tumours (TGCT) and other indications. SynOx is backed by a strong investor syndicate with long and successful backgrounds in building biopharma companies.
Company Details
- Employees
- 26
- Founded
- -
- Address
- Wilton Terrace, 7/8,ireland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://synoxtherapeutics.com/
- HQ
- Dublin City, County Dublin
Synox Therapeutics Questions
Synox Therapeutics's website is https://synoxtherapeutics.com/
Synox Therapeutics's LinkedIn profile is https://ie.linkedin.com/company/synox-therapeutics
Synox Therapeutics has
26 employees.
View email and phone details for 26
employees at Synox Therapeutics.
Synox Therapeutics's industry is
Biotechnology Research
Synox Therapeutics's top competitors are
Axonis Therapeutics,
Carrick Therapeutics,
Onk Therapeutics,
Evommune,
Blue Earth Therapeutics,
Resolution Therapeutics,
Pheon Therapeutics,
Myricx Bio,
Leal Therapeutics,
Amber Therapeutics.
Synox Therapeutics's categories are Biotechnology Research
Synox Therapeutics's founding year is 2020
